Efficacy and safety of novel oral anticoagulants for treatment of acute venous thromboembolism: direct and adjusted indirect meta-analysis of randomised controlled trials

Pas encore traduit Pas encore traduit
Catégorie Structured summary of systematic reviews
JournalDatabase of Abstracts of Reviews of Effects (DARE)
Year 2012
CRD SUMMARY: This review concluded that novel oral anticoagulants had a similar risk of recurrence of acute venous thromboembolism and all-cause mortality when compared with vitamin K antagonists; rivaroxaban was associated with a reduced risk of bleeding. The authors acknowledged limitations in the evidence that mean the results of the review should be treated with caution.
Epistemonikos ID: b1a3d239f3eeacc30cd05a81e7d6e4164d99b984
First added on: Jan 13, 2015